1,800
Participants
Start Date
February 27, 2023
Primary Completion Date
May 5, 2023
Study Completion Date
May 5, 2023
Experimental 23-valent Pneumococcal
The investigational vaccine was manufactured by Sinovac Biotech Co., Ltd.25μg each for serotypes 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B,17F,18C, 19A, 19F, 20, 22F, 23F, and 33F in 0.5 mL of sodium chloride mixture per injection.
The First People's Hospital of Yuanping Medical Group, Yuanping
Salt Lake District Center for Disease Control and Prevention, Yuncheng
Sinovac Biotech Co., Ltd
INDUSTRY